Provider fact sheet · dataset v2026.08.14-4 · last touched 2026-08-14
Henry Meds: GLP-1 programs, prices, and verification status (2026)
Henry Meds is a unverified entry in our universe. The cheapest independently reported flat bundle in our ledger at ~$179/month — with the giant asterisk that the headline covers tablet and sublingual formats, which have no published human absorption data for tirzepatide.
Programs and pricing, in plain sentences
tirzepatide (oral/sublingual tablet) — status: unverified.
tirzepatide (injection) — status: unverified. Key fields: price rises with dose. ~$399 first month, ~$449 recurring, higher doses ~+$100/mo, per third-party check
Every figure above carries its status — operator claims come from the provider, reported from third parties we cite, verified only after our own checkout walk. Machine-readable version: providers.json.
Update — August 14, 2026: A third injectable figure joins the record: the April 2026 tirzepatide.us.com comparison lists Henry compounded tirzepatide at $269/mo starting — against the ~$399–449 injectable band and ~$179 tablet bundle in earlier reports. Three conflicting injectable figures now sit in the dataset with their sources; per policy we average nothing and the checkout decides. The tablet-format caveat is unchanged.
Verification status and open items
Current status: unverified, last touched 2026-08-14. Open verification items: dispensing pharmacy identity, cancellation terms. Source on file: www.rxpepsdirect.com. Corrections land within 48 hours via the public log — if your checkout contradicts this page, that report changes the dataset.
How Henry Meds fits the market
The cheapest independently reported flat bundle in our ledger at ~$179/month — with the giant asterisk that the headline covers tablet and sublingual formats, which have no published human absorption data for tirzepatide. Third-party checks put Henry's injectable near $399–449. The gap between those two numbers is the whole tablet story. Head-to-head: Henry Meds vs NexLife. Where it lands overall: the price ladder, the category winners, and the program finder all compute from the same dataset this page renders.
Advertising disclosure: outbound provider links may be commission-bearing; our partner relationship with NexLife is disclosed on the ownership page and never alters statuses or rankings.